Cardiovascular Disease (CVD): Types, Global Burden & Prevention

Cardiovascular Disease (CVD) encompasses all disorders of the heart and blood vessels. It is the leading cause of death globally, claiming an estimated 18.6 million lives annually (WHO, 2022)—32% of all deaths.

Major Categories

Modifiable Risk Factors (INTERHEART: 90% Population Attributable Risk)

  1. Dyslipidemia (ApoB/ApoA1 ratio)
  2. Smoking/tobacco
  3. Hypertension
  4. Diabetes / insulin resistance
  5. Abdominal obesity
  6. Psychosocial stress / depression
  7. Low fruit/vegetable intake
  8. Physical inactivity
  9. Alcohol (heavy/binge)

Non-Modifiable

Age, sex (male > premenopausal female), family history/genetics, race/ethnicity (South Asian, Black higher risk).

Prevention Strategy

  • Primordial: Prevent risk factor development (childhood nutrition, activity, smoke-free).
  • Primary: Treat risk factors before disease (statins, antihypertensives, lifestyle).
  • Secondary: Prevent recurrence post-event (antiplatelets, statins, beta-blockers, ACEi/ARB, SGLT2i, cardiac rehab).

Global target (WHO): 25% relative reduction in premature CVD mortality by 2025 (25×25). Progress is off-track. Equitable implementation of evidence-based policies (tobacco tax, salt reduction, trans-fat bans, primary care access) is essential.

Medical Billing - Related Articles

Health Sciences © https://www.222health.com

CategoryConditionsPathophysiology
Coronary Heart Disease (CHD)Angina, MI, silent ischemia, sudden cardiac deathAtherosclerotic plaque → coronary stenosis/occlusion → myocardial ischemia/infarction
Cerebrovascular DiseaseIschemic stroke, hemorrhagic stroke, TIAAtherosclerosis, embolism, small vessel disease → brain ischemia/hemorrhage
Peripheral Artery Disease (PAD)Claudication, critical limb ischemiaAtherosclerosis of iliac, femoral, tibial arteries → limb hypoperfusion
Heart FailureHFrEF, HFpEF, right-sided failureImpaired filling/ejection → inadequate cardiac output for metabolic needs
ArrhythmiasAFib, VT/VF, bradyarrhythmiasAbnormal impulse formation/conduction
Valvular Heart DiseaseStenosis/regurgitation (aortic, mitral, tricuspid, pulmonary)Degenerative, rheumatic, congenital, infective
Congenital Heart DiseaseSeptal defects, tetralogy, transposition, etc.Structural anomalies from embryologic development
Rheumatic Heart DiseasePost-streptococcal valvular damageAutoimmune cross-reaction (Group A Strep) → valve fibrosis
CardiomyopathiesDilated, hypertrophic, restrictive, ARVCPrimary myocardial disorders (genetic, acquired)
Deep Vein Thrombosis / PEVenous thromboembolismVirchow's triad → venous clot → pulmonary embolism
Aortic DiseaseAneurysm, dissectionMedial degeneration, hypertension, connective tissue disorders